InvestorsHub Logo
Followers 5
Posts 1109
Boards Moderated 0
Alias Born 05/02/2014

Re: flybabyfly post# 23975

Wednesday, 07/08/2015 10:38:16 AM

Wednesday, July 08, 2015 10:38:16 AM

Post# of 140475
Well if it was Titan, and Titan is going to be testing, refining, and seeking regulatory approvals over the next two years (let alone trying to raise money), what is JnJ/Google/Ethicon doing in that time? They announced their collaboration about two years early. Another way to look at it is that Titan's own published timeline is now highly suspect. We shareholders are not going to see what SPORT looks like as it is developed? CE and FDA approval will be based on some "early version" of SPORT, already two years behind.

Also, if Titan is the chosen platform, doesn't it make sense that money is provided NOW to move this wonderful collaboration along. JnJ/G/E isn't going to sit around with their thumb in their butt and watch Titan slowly go through the hoops.

I agree Raven II is developmental testbed, but if JnJ/G/E will have a platform out there in two years, what makes a SPORT collaboration a distinctive JnJ/G/E product? More likely is that a Raven II - like system will be developed with very advanced Google ideas that will set it apart from ISRG products.

JnJ/G/E would need to be actually rolling up shirtsleeves now, as we speak, in order to be adding anything to SPORT that makes it any different from the tested, rollout that Titan tells us about.

I honestly don't think you can keep that all under wraps at this time. We would be talking about five companies actively involved: Titan, Ximedica, JnJ/Ethicon, and Google. There would be some chatter, somewhere that we would pick up.